S.R. Byrn

758 total citations
39 papers, 593 citations indexed

About

S.R. Byrn is a scholar working on Organic Chemistry, Materials Chemistry and Molecular Biology. According to data from OpenAlex, S.R. Byrn has authored 39 papers receiving a total of 593 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Organic Chemistry, 13 papers in Materials Chemistry and 12 papers in Molecular Biology. Recurrent topics in S.R. Byrn's work include Crystallization and Solubility Studies (7 papers), Drug Solubulity and Delivery Systems (5 papers) and DNA and Nucleic Acid Chemistry (5 papers). S.R. Byrn is often cited by papers focused on Crystallization and Solubility Studies (7 papers), Drug Solubulity and Delivery Systems (5 papers) and DNA and Nucleic Acid Chemistry (5 papers). S.R. Byrn collaborates with scholars based in United States and United Kingdom. S.R. Byrn's co-authors include Ann T. McKenzie, Gregory A. Stephenson, William B. Gleason, Ralph R. Pfeiffer, David Grant, P. L. Fuchs, A. Alkofahi, John M. Cassady, Richard B. Borgens and Chen‐Sheng Yeh and has published in prestigious journals such as Journal of the American Chemical Society, Chemistry of Materials and Advanced Drug Delivery Reviews.

In The Last Decade

S.R. Byrn

36 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S.R. Byrn United States 12 225 144 138 90 89 39 593
Lars Mörch Sweden 15 325 1.4× 196 1.4× 60 0.4× 69 0.8× 110 1.2× 70 635
Kunisi S. Venkatasubban United States 11 212 0.9× 249 1.7× 50 0.4× 87 1.0× 135 1.5× 39 577
Paul D. Wood Canada 13 213 0.9× 176 1.2× 141 1.0× 202 2.2× 40 0.4× 15 568
Juan Crugeiras Spain 14 351 1.6× 227 1.6× 103 0.7× 51 0.6× 79 0.9× 32 588
Vernon G. S. Box United States 13 284 1.3× 206 1.4× 46 0.3× 72 0.8× 49 0.6× 54 503
Cecilia Cortez United States 15 475 2.1× 240 1.7× 142 1.0× 40 0.4× 83 0.9× 41 816
Thomas W. Whaley United States 12 184 0.8× 223 1.5× 79 0.6× 24 0.3× 151 1.7× 32 546
Ramanathan Mahedevan 14 345 1.5× 229 1.6× 64 0.5× 45 0.5× 74 0.8× 64 630
Jelena Veljković Croatia 12 241 1.1× 112 0.8× 102 0.7× 70 0.8× 62 0.7× 27 473
Maria M. Toteva United States 13 563 2.5× 264 1.8× 92 0.7× 116 1.3× 134 1.5× 32 842

Countries citing papers authored by S.R. Byrn

Since Specialization
Citations

This map shows the geographic impact of S.R. Byrn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.R. Byrn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.R. Byrn more than expected).

Fields of papers citing papers by S.R. Byrn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S.R. Byrn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.R. Byrn. The network helps show where S.R. Byrn may publish in the future.

Co-authorship network of co-authors of S.R. Byrn

This figure shows the co-authorship network connecting the top 25 collaborators of S.R. Byrn. A scholar is included among the top collaborators of S.R. Byrn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S.R. Byrn. S.R. Byrn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Benmore, Chris J., et al.. (2024). Hydrogen Bonding in Amorphous Indomethacin. Pharmaceutics. 16(8). 1002–1002. 2 indexed citations
2.
Benmore, Chris J., et al.. (2023). X-ray Diffraction of Water in Polyvinylpyrrolidone. Molecular Pharmaceutics. 20(7). 3645–3652. 11 indexed citations
3.
Benmore, Chris J., M. Harish Bhat, Brian R. Cherry, et al.. (2021). A High Energy X-ray Diffraction Study of Amorphous Indomethacin. Journal of Pharmaceutical Sciences. 111(3). 818–824. 6 indexed citations
4.
Weber, J. K. Richard, Chris J. Benmore, Kamlesh Suthar, et al.. (2016). Using containerless methods to develop amorphous pharmaceuticals. Biochimica et Biophysica Acta (BBA) - General Subjects. 1861(1). 3686–3692. 5 indexed citations
5.
Weber, J. K. Richard, Chris J. Benmore, Jöerg C. Neuefeind, et al.. (2013). A neutron-X-ray, NMR and calorimetric study of glassy Probucol synthesized using containerless techniques. Chemical Physics. 424. 89–92. 11 indexed citations
6.
McBride, Jennifer M., Daniel T. Smith, S.R. Byrn, Richard B. Borgens, & Riyi Shi. (2007). 4-Aminopyridine derivatives enhance impulse conduction in guinea-pig spinal cord following traumatic injury. Neuroscience. 148(1). 44–52. 20 indexed citations
7.
Shi, Rui, et al.. (2005). Development of novel 4-aminopyridine derivatives as potential treatments for neurological injury and disease. European Journal of Medicinal Chemistry. 40(9). 908–917. 32 indexed citations
8.
Suryanarayanan, Raj & S.R. Byrn. (2001). Preface. Advanced Drug Delivery Reviews. 48(1). 1–2. 8 indexed citations
9.
Fanwick, P.E., et al.. (1997). Cholamide Dihydrate. Acta Crystallographica Section C Crystal Structure Communications. 53(4). 480–482.
10.
Byrn, S.R., et al.. (1996). Sodium Cholate Methanolate and Sodium Cholate 2-Propanolate. Acta Crystallographica Section C Crystal Structure Communications. 52(10). 2495–2499. 2 indexed citations
11.
Byrn, S.R., Ralph R. Pfeiffer, Gregory A. Stephenson, David Grant, & William B. Gleason. (1994). Solid-State Pharmaceutical Chemistry. Chemistry of Materials. 6(8). 1148–1158. 137 indexed citations
12.
Stowell, Joseph G., Pascal H. Toma, & S.R. Byrn. (1991). 9,10-Dihydro-9-methylacridine. Acta Crystallographica Section C Crystal Structure Communications. 47(8). 1635–1637. 1 indexed citations
13.
Anderson, J. E., et al.. (1990). Tubulosine: An Antitumor Constituent of Pogonopus speciosus. Journal of Natural Products. 53(4). 1009–1014. 26 indexed citations
14.
Alkofahi, A., et al.. (1989). Goniotriol from Goniathalamus giganteus. Journal of Natural Products. 52(6). 1371–1373. 59 indexed citations
15.
Ho, David K., S. Masuda, Mohamed I. Abou‐Shoer, et al.. (1987). Structure and stereochemistry of psorospermin and related cytotoxic dihydrofuranoxanthones from Psorospermum febrifugum. The Journal of Organic Chemistry. 52(3). 412–418. 42 indexed citations
16.
Byrn, S.R., et al.. (1984). Degradation of Crystalline Ergocalciferol [Vitamin D2, (3β, 5Z, 22E)- 9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol]. Journal of Pharmaceutical Sciences. 73(9). 1322–1323. 3 indexed citations
17.
18.
Cassady, John M., et al.. (1978). Potential antitumor agents. Synthesis, reactivity, and cytotoxicity of .alpha.-methylene carbonyl compounds. Journal of Medicinal Chemistry. 21(8). 815–819. 31 indexed citations
19.
Byrn, S.R., et al.. (1971). Structures of two head-to-head allene dimers. Journal of the American Chemical Society. 93(24). 6680–6682. 12 indexed citations
20.
Curtin, David & S.R. Byrn. (1969). Stereoisomerism at the oxygen-carbon single bond due to hydrogen bonding. Structures of the yellow and white crystalline forms of dimethyl 3,6-dichloro-2,5-dihydroxyterephthalate. Journal of the American Chemical Society. 91(7). 1865–1866. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026